Literature DB >> 11576035

Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia.

M Weiser1, A Reichenberg, J Rabinowitz, Z Kaplan, M Mark, E Bodner, D Nahon, M Davidson.   

Abstract

BACKGROUND: Nonpsychotic psychiatric symptoms may occasionally herald the later development of schizophrenia. This study followed a population-based cohort of adolescents with nonpsychotic, non-major affective psychiatric disorders to ascertain future hospitalization for schizophrenia.
METHODS: Results of the medical and mental health assessments on 124 24416- to 17-year-old males screened by the Israeli draft board were cross-linked with the National Psychiatric Hospitalization case registry, which contains data on all psychiatric hospitalizations in the country, during a 4- to 8-year-long follow-up through age 25 years. In the cohort, 9365 adolescents were assigned a nonpsychotic, non-major affective diagnosis by the draft board.
RESULTS: After excluding 167 adolescents who were hospitalized before or up to 1 year after the draft board assessment, 1.03% of the adolescents assigned a nonpsychotic, non-major affective psychiatric diagnosis, compared with only 0.23% of the adolescents without any psychiatric diagnosis, were later hospitalized for schizophrenia. Of the patients with schizophrenia, 26.8%, compared with only 7.4% in the general population, had been assigned a nonpsychotic, non-major affective psychiatric diagnosis in adolescence (overall odds ratio [OR], 4.5; 95% confidence interval [CI], 3.6-5.6), ranging from OR, 21.5 (95% CI, 12.6-36.6) for schizophrenia spectrum personality disorders to OR, 3.6 (95% CI, 2.1-6.2) for neurosis.
CONCLUSION: These results reflect the relatively common finding of impaired functioning in patients later hospitalized for schizophrenia and the relatively low power of these disorders in predicting schizophrenia.

Entities:  

Mesh:

Year:  2001        PMID: 11576035     DOI: 10.1001/archpsyc.58.10.959

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  13 in total

Review 1.  How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia?

Authors:  Katherine Seeber; Kristin S Cadenhead
Journal:  Curr Psychiatry Rep       Date:  2005-03       Impact factor: 5.285

2.  Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L.

Authors:  Mark Weiser; Kyra Kanyas; Dolores Malaspina; Philip D Harvey; Ittai Glick; Deborah Goetz; Osnat Karni; Avi Yakir; Neil Turetsky; Shmuel Fennig; Daniella Nahon; Bernard Lerer; Michael Davidson
Journal:  Compr Psychiatry       Date:  2005 Jan-Feb       Impact factor: 3.735

3.  Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?

Authors:  Stephen M Lawrie; Bayanne Olabi; Jeremy Hall; Andrew M McIntosh
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

4.  Family history of schizophrenia and bipolar disorder as risk factors for autism.

Authors:  Patrick F Sullivan; Cecilia Magnusson; Abraham Reichenberg; Marcus Boman; Christina Dalman; Michael Davidson; Eyal Fruchter; Christina M Hultman; Michael Lundberg; Niklas Långström; Mark Weiser; Anna C Svensson; Paul Lichtenstein
Journal:  Arch Gen Psychiatry       Date:  2012-11

Review 5.  Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

Authors:  Rodrigo D Paz; Sonia Tardito; Marco Atzori; Kuei Y Tseng
Journal:  Eur Neuropsychopharmacol       Date:  2008-07-23       Impact factor: 4.600

Review 6.  Hypothesis: grandiosity and guilt cause paranoia; paranoid schizophrenia is a psychotic mood disorder; a review.

Authors:  Charles Raymond Lake
Journal:  Schizophr Bull       Date:  2007-12-01       Impact factor: 9.306

Review 7.  Role of Hybrid Brain Imaging in Neuropsychiatric Disorders.

Authors:  Amer M Burhan; Nicole M Marlatt; Lena Palaniyappan; Udunna C Anazodo; Frank S Prato
Journal:  Diagnostics (Basel)       Date:  2015-12-04

Review 8.  The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis.

Authors:  Michael Davidson; Asaf Caspi; Shlomo Noy
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

Review 9.  Treating early psychosis: who, what, and when?

Authors:  Barbara A Cornblatt; Andrea M Auther
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

10.  What makes the psychosis 'clinical high risk' state risky: psychosis itself or the co-presence of a non-psychotic disorder?

Authors:  Laila Hasmi; Lotta-Katrin Pries; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Maarten Bak; Gunter Kenis; Alexander Richards; Bochao D Lin; Michael C O'Donovan; Jurjen J Luykx; Bart P F Rutten; Sinan Guloksuz; Jim van Os
Journal:  Epidemiol Psychiatr Sci       Date:  2021-07-06       Impact factor: 6.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.